You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
11 February 2026 - Investment company IP Group plc (LSE: IPO) announced on Wednesday that its portfolio company Microbiotica Ltd has reported positive results from its Phase 1b first-in-human COMPOSER-1 trial of MB310 in patients with ulcerative coli...
11 February 2026 - Artificial heart technology company Scandinavian Real Heart AB (Nasdaq Stockholm First North Growth Market:HEART) announced on Wednesday that it has received patent approval from the European Patent Office for its Realheart TAH (To...
11 February 2026 - Next-generation molecular diagnostics company BillionToOne Inc (Nasdaq:BLLN) announced on Tuesday the release of Northstar PGx and Northstar Select CH as add-on applications for Northstar Select, its therapy selection liquid biopsy...
11 February 2026 - Clinical-stage biopharmaceutical company Iterion Therapeutics announced on Tuesday that the first patient has been dosed in a clinical study evaluating tegavivint, a first-in-class inhibitor of the Wnt/beta-catenin pathway, in comb...
10 February 2026 - US pharmaceutical company Eli Lilly and Company (NYSE:LLY) announced on Monday that it has signed a definitive agreement to acquire Orna Therapeutics Inc, a biotechnology company focused on engineering immune cells in vivo.Orna is ...
10 February 2026 - AI-powered drug discovery and biodefence company Lunai Bioworks (NASDAQ:LNAI) announced on Monday that it has launched a new oncology collaboration with a clinical-stage partner to evaluate data from a randomised Phase 2 metastatic...